vs
KORE Group Holdings, Inc.（KORE）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是KORE Group Holdings, Inc.的1.7倍（$127.1M vs $73.9M），再鼎医药同比增速更快（17.1% vs 0.7%），KORE Group Holdings, Inc.自由现金流更多（$9.4M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -1.4%）
KORE Wireless是一家上市物联网连接服务商，提供物联网连接、托管服务及相关解决方案，业务覆盖医疗健康、物流、车队管理、公用事业、工业自动化等多个领域，目前在全球拥有超过2000万活跃连接数。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
KORE vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.7倍
$73.9M
营收增速更快
ZLAB
高出16.4%
0.7%
自由现金流更多
KORE
多$36.1M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.9M | $127.1M |
| 净利润 | $-18.5M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | -0.8% | -54.6% |
| 净利率 | -25.0% | — |
| 营收同比 | 0.7% | 17.1% |
| 净利润同比 | 27.4% | — |
| 每股收益（稀释后） | $-0.92 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KOREZLAB
| Q4 25 | $73.9M | $127.1M | ||
| Q3 25 | $68.7M | $115.4M | ||
| Q2 25 | $71.3M | $109.1M | ||
| Q1 25 | $72.1M | $105.7M | ||
| Q4 24 | $73.3M | $108.5M | ||
| Q3 24 | $68.9M | $101.8M | ||
| Q2 24 | $67.9M | $100.1M | ||
| Q1 24 | $76.0M | $87.1M |
净利润KOREZLAB
| Q4 25 | $-18.5M | — | ||
| Q3 25 | $-12.7M | $-36.0M | ||
| Q2 25 | $-16.9M | $-40.7M | ||
| Q1 25 | $-14.9M | $-48.4M | ||
| Q4 24 | $-25.4M | — | ||
| Q3 24 | $-19.4M | $-41.7M | ||
| Q2 24 | $-83.6M | $-80.3M | ||
| Q1 24 | $-17.6M | $-53.5M |
毛利率KOREZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率KOREZLAB
| Q4 25 | -0.8% | -54.6% | ||
| Q3 25 | -6.1% | -42.3% | ||
| Q2 25 | -7.3% | -50.3% | ||
| Q1 25 | -3.4% | -53.3% | ||
| Q4 24 | -17.8% | -62.6% | ||
| Q3 24 | -8.2% | -66.6% | ||
| Q2 24 | -113.0% | -76.0% | ||
| Q1 24 | -9.7% | -80.7% |
净利率KOREZLAB
| Q4 25 | -25.0% | — | ||
| Q3 25 | -18.5% | -31.2% | ||
| Q2 25 | -23.7% | -37.3% | ||
| Q1 25 | -20.7% | -45.8% | ||
| Q4 24 | -34.7% | — | ||
| Q3 24 | -28.2% | -40.9% | ||
| Q2 24 | -123.2% | -80.2% | ||
| Q1 24 | -23.1% | -61.4% |
每股收益（稀释后）KOREZLAB
| Q4 25 | $-0.92 | $-0.05 | ||
| Q3 25 | $-0.64 | $-0.03 | ||
| Q2 25 | $-0.86 | $-0.04 | ||
| Q1 25 | $-0.77 | $-0.04 | ||
| Q4 24 | $-1.29 | $-0.09 | ||
| Q3 24 | $-1.00 | $-0.04 | ||
| Q2 24 | $-4.37 | $-0.08 | ||
| Q1 24 | $-0.93 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.7M | $689.6M |
| 总债务越低越好 | $301.3M | — |
| 股东权益账面价值 | $-163.8M | $715.5M |
| 总资产 | $410.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KOREZLAB
| Q4 25 | $26.7M | $689.6M | ||
| Q3 25 | $19.3M | $717.2M | ||
| Q2 25 | $21.0M | $732.2M | ||
| Q1 25 | $19.7M | $757.3M | ||
| Q4 24 | $19.4M | $779.7M | ||
| Q3 24 | $18.6M | $616.1M | ||
| Q2 24 | $22.3M | $630.0M | ||
| Q1 24 | $23.0M | $650.8M |
总债务KOREZLAB
| Q4 25 | $301.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $303.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KOREZLAB
| Q4 25 | $-163.8M | $715.5M | ||
| Q3 25 | $-145.7M | $759.9M | ||
| Q2 25 | $-133.5M | $791.7M | ||
| Q1 25 | $-114.9M | $810.8M | ||
| Q4 24 | $-99.6M | $840.9M | ||
| Q3 24 | $-77.2M | $667.7M | ||
| Q2 24 | $-57.2M | $704.2M | ||
| Q1 24 | $22.3M | $762.2M |
总资产KOREZLAB
| Q4 25 | $410.5M | $1.2B | ||
| Q3 25 | $423.4M | $1.2B | ||
| Q2 25 | $432.9M | $1.2B | ||
| Q1 25 | $445.1M | $1.2B | ||
| Q4 24 | $455.8M | $1.2B | ||
| Q3 24 | $473.9M | $985.3M | ||
| Q2 24 | $487.7M | $987.4M | ||
| Q1 24 | $576.6M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.4M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $9.4M | $-26.7M |
| 自由现金流率自由现金流/营收 | 12.7% | -21.0% |
| 资本支出强度资本支出/营收 | 1.5% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $15.8M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流KOREZLAB
| Q4 25 | $10.4M | $-26.0M | ||
| Q3 25 | $1.1M | $-32.0M | ||
| Q2 25 | $4.1M | $-31.0M | ||
| Q1 25 | $2.9M | $-61.7M | ||
| Q4 24 | $2.1M | $-55.8M | ||
| Q3 24 | $1.2M | $-26.8M | ||
| Q2 24 | $4.0M | $-42.2M | ||
| Q1 24 | $1.9M | $-90.1M |
自由现金流KOREZLAB
| Q4 25 | $9.4M | $-26.7M | ||
| Q3 25 | $879.0K | $-35.0M | ||
| Q2 25 | $2.8M | $-33.9M | ||
| Q1 25 | $2.7M | $-63.2M | ||
| Q4 24 | $2.0M | $-58.4M | ||
| Q3 24 | $973.0K | $-28.2M | ||
| Q2 24 | $3.1M | $-42.9M | ||
| Q1 24 | $1.0M | $-91.1M |
自由现金流率KOREZLAB
| Q4 25 | 12.7% | -21.0% | ||
| Q3 25 | 1.3% | -30.4% | ||
| Q2 25 | 4.0% | -31.1% | ||
| Q1 25 | 3.8% | -59.9% | ||
| Q4 24 | 2.7% | -53.8% | ||
| Q3 24 | 1.4% | -27.7% | ||
| Q2 24 | 4.6% | -42.9% | ||
| Q1 24 | 1.4% | -104.5% |
资本支出强度KOREZLAB
| Q4 25 | 1.5% | 0.5% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 1.8% | 2.6% | ||
| Q1 25 | 0.2% | 1.5% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 0.3% | 1.3% | ||
| Q2 24 | 1.3% | 0.7% | ||
| Q1 24 | 1.2% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KORE
| Io T Connectivity And Solutions Services | $55.9M | 76% |
| Hardware Sales | $15.4M | 21% |
| Deployment Services Professional Services Referral Services And Other | $2.5M | 3% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
